Recombinant Human PRKCE Protein
The product is for non-human research only. Not for therapeutic or veterinary use.
Catalog No: bt-222330
Formulation: PRKCE is supplied in 20mM Tris, pH 7.4, 0.1M NaCl, 20% glycerol, 1mM DTT, 0.1mM EDTA, 0.2mM PMSF, 1mM benzamidine and 0.03% Brij-35.
Source: Sf9 insect cells.
|Product Name||Recombinant Human PRKCE Protein|
|Formulation||PRKCE is supplied in 20mM Tris, pH 7.4, 0.1M NaCl, 20% glycerol, 1mM DTT, 0.1mM EDTA, 0.2mM PMSF, 1mM benzamidine and 0.03% Brij-35.|
|Host Species||Homo sapiens (Human)|
|Product Background||Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been shown to be involved in many different cellular functions, such as neuron channel activation, apoptosis, cardioprotection from ischemia, heat shock response, as well as insulin exocytosis. Knockout studies in mice suggest that this kinase is important for lipopolysaccharide (LPS)-mediated signaling in activated macrophages and may also play a role in controlling anxiety-like behavior.|
|Product Memo||PRKCE Human Protein Kinase C epsilon Human Recombinant|
|Product Type||Recombinant Protein|
|Purity||>90% as determined by SDS-PAGE.|
|Source||Sf9 insect cells.|
|Stability||Recombinant protein is stable up to 1 year at -80℃|
|Synonym||Protein kinase C epsilon type, EC 188.8.131.52, nPKC-epsilon, PRKCE, PKCE, MGC125656, MGC125657|
|Usage||Our recombinant proteins are For Research Use Only. This product is not intended or approved for human, diagnostics or veterinary use.|
|Last Modified||Mar 08 2019|